How Wavera shows up
in your day.
Four agents. Four workflows. One shared clinical, financial, and operational data model. Each is live today — pick the one you want to see in your clinic first.
Ambient notes that pay attention so you can.
Take Luna into the exam room, or dictate between patients. She writes the note, extracts the plan, queues the orders, and suggests codes — while you stay present with the patient in front of you.
Ambient when you're with a patient. Dictation when you're not.
Luna supports both modes. In the room, she listens and captures the visit passively. Between patients, dictate a note in plain English and she structures it into problems, plan, and orders.
Transparent AI.
Every answer traces to its source.
Every clinical recommendation made by our agents is traceable to its source — NCCN guidelines, tumor board reports, pathology findings, imaging, or historical patient data. No hallucinations, no orphan claims. Click a citation; see the exact sentence it came from, highlighted in the original document.
This is a 62-year-old male with metastatic NSCLC characterized by KEAP1 / SMARCA4 / TP53 co-mutations. He has a High Tumor Mutational Burden (TMB-H) at 19 mutations/Mb. He benefited from first-line chemo-immunotherapy but developed severe, grade 3+ immune-related pneumonitis, which is an absolute contraindication to further checkpoint inhibitor therapy.
PD-L1: Tumor Proportion Score (TPS) 0%. Molecular: NGS/Genomics confirm KEAP1, TP53 and SMARCA4 mutations. No actionable driver mutations (EGFR, ALK, ROS1) identified.
Endocrine: Adrenal insufficiency (managed on hydrocortisone). Hematologic: Chronic iron-deficiency anemia on iron sucrose repletion.
Patient has 1metastatic NSCLC with KEAP1/SMARCA4/TP53 co-mutations, PD-L1 0% 2, and TMB-high status.
Further immune-checkpoint inhibitor therapy is contraindicated due to grade 3 pneumonitis 3.
Managed adrenal insufficiency 4 on hydrocortisone replacement.
Build guideline-aligned regimens through natural language.
Ask in plain language. Atlas pulls from notes, tumor board summaries, imaging, and the current NCCN guideline — then proposes a regimen. Preview orders and the infusion timeline, approve, and Wavera schedules the cycles, arms lab holds, and monitors toxicity.
Prior auths that write and submit themselves.
When a regimen needs a PA, the revenue agent reads the chart by section — problems, labs, imaging, prior therapy, provider — fills the payer form, and transmits it through fax and Availity in parallel. You sign off when it lands back approved.
Ask your entire practice a question.
Agents run in the background across every chart, claim, and inventory record in the tenant. Trial matching, margin analysis, demand forecasts, revenue leak detection — all surfaced as chat answers you can trust because the sources are linked.
See these in your workflow.
30-minute walkthrough with a founder. We'll demo whichever agent maps best to the biggest tax on your day.